The anti-malarial atovaquone increases radiosensitivity by alleviating tumour hypoxia (Nature communications, 2016)

(untitled) - Ashton, T; Fokas, E; Kunz-Schughart, L; Folkes, L; Anbalagan, S; Huether, M; Kelly, C; Pirovano, G; Buffa, F; Hammond, E; Stratford, M; Muschel, R; et al.